CIK 0001527352 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275566468
- Phone
- (832) 260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award 10% owner acquired 83,333 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 36,459 shares (grant or award)
- 4 Grant or award Director acquired 36,459 shares (grant or award)
- 4 Grant or award Director acquired 36,459 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Sr. VP - Quality, Regulatory bought 6,000 shares at $2.20 ($13,200)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Medical Officer bought 1,000 shares at $3.10 ($3,100)
Page 1 of 3 · 57 filings